<p><a target="_blank" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2502457?query=TOC&cid=DM2446864_NEJM_Non_Subscriber&bid=-829757204">Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients</a></p><p>* <a target="_blank" href="https://academic.oup.com/ofid/article/12/9/ofaf553/8246175">Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study</a></p><p><a target="_blank" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2515043?query=TOC">Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage</a></p><p>* <a target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28050754/">Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study</a></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.sensible-med.com/subscribe?utm_medium=podcast&utm_campaign=CTA_2">www.sensible-med.com/subscribe</a>